Zacks: Analysts Set $3.00 Price Target for Concord Medical Services Hldg Ltd (CCM)

Shares of Concord Medical Services Hldg Ltd (NYSE:CCM) have been given an average broker rating score of 3.70 (Sell) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a sell rating.

Brokerages have set a 1 year consensus price target of $3.00 for the company and are predicting that the company will post $0.01 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Concord Medical Services an industry rank of 65 out of 256 based on the ratings given to its competitors.

Separately, Zacks Investment Research upgraded Concord Medical Services from a “sell” rating to a “hold” rating in a research report on Wednesday, September 19th.

Shares of CCM stock opened at $3.40 on Thursday. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.06. Concord Medical Services has a 1 year low of $2.46 and a 1 year high of $4.20. The firm has a market cap of $154.38 million, a price-to-earnings ratio of -3.33 and a beta of 0.61.

About Concord Medical Services

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services.

Featured Story: What is a good rate of return for a mutual fund?

Get a free copy of the Zacks research report on Concord Medical Services (CCM)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit